Literature DB >> 19628910

False negative results of QuantiFERON TB-2G test in patients with active tuberculosis.

Yoshihiro Kobashi1, Hiroki Shimizu, Yoshihiro Ohue, Keiji Mouri, Yasushi Obase, Naoyuki Miyashita, Mikio Oka.   

Abstract

Ten of 140 patients (7.1%) showed negative results on a QFT-2G test. The 10 patients consisted of seven males and three females (mean age: 66.0 years old). Three of the 10 patients had no clinical symptoms and no underlying diseases. They showed negative results on the QFT-2G test repeatedly within 1 month and a negative response on a tuberculin skin test (TST). Six of the seven remaining patients were of advanced age, and all of them had underlying diseases. Although all seven patients showed negative results on the QFT-2G test repeatedly within 1 month, one of them showed a negative response on TST. The lymphocyte count was within the normal range in three patients with nutritional conditions. Although five of nine patients with pulmonary tuberculosis had cavitary lesions, six had lesions within one-third of the unilateral lung field. The clinical effect in all patients was good. We suspect that there are two patterns by which false negative results are shown on QFT-2G tests; one pattern involves the decrease of interferon-gamma production due to advanced patient age or lymphocytopenia, and in the other lymphocytes cannot produce interferon-gamma for Mycobacterium tuberculosis-specific antigen in young patients without underlying disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628910

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  7 in total

1.  Risk factors for false-negative results of T-SPOT.TB and tuberculin skin test in extrapulmonary tuberculosis.

Authors:  Y-M Lee; K-H Park; S-M Kim; S J Park; S-O Lee; S-H Choi; Y S Kim; J H Woo; S-H Kim
Journal:  Infection       Date:  2013-08-14       Impact factor: 3.553

2.  Is the sensitivity of the QuantiFERON-TB gold in-tube test lower than that of T-SPOT.TB in patients with miliary tuberculosis?

Authors:  Sun In Hong; Yu-Mi Lee; Ki-Ho Park; Sung-Han Kim
Journal:  Clin Infect Dis       Date:  2014-04-11       Impact factor: 9.079

3.  Factors that Predict Negative Results of QuantiFERON-TB Gold In-Tube Test in Patients with Culture-Confirmed Tuberculosis: A Multicenter Retrospective Cohort Study.

Authors:  Yong-Soo Kwon; Yee Hyung Kim; Kyeongman Jeon; Byeong-Ho Jeong; Yon Ju Ryu; Jae Chol Choi; Ho Cheol Kim; Won-Jung Koh
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

4.  Diagnostic Usefulness of IFN-Gamma Releasing Assays Compared With Conventional Tests in Patients With Disseminated Tuberculosis.

Authors:  Shi Nae Yu; Jiwon Jung; Yong-Kyun Kim; Ju Young Lee; Sun-Mi Kim; Su Jin Park; Sang-Oh Lee; Sang-Ho Choi; Yang Soo Kim; Jun Hee Woo; Sung-Han Kim
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

5.  Characteristics Associated with Negative Interferon-γ Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013-2015.

Authors:  Duc T Nguyen; Larry D Teeter; Julie Graves; Edward A Graviss
Journal:  Emerg Infect Dis       Date:  2018-03       Impact factor: 6.883

6.  Evaluation of risk factors for false-negative results with an antigen-specific peripheral blood-based quantitative T cell assay (T-SPOT®. TB) in the diagnosis of active tuberculosis: A large-scale retrospective study in China.

Authors:  Chi Yang; Shaojun Zhang; Lan Yao; Lin Fan
Journal:  J Int Med Res       Date:  2018-03-12       Impact factor: 1.671

7.  The seroconversion rate of QuantiFERON-TB Gold In-Tube test in psoriatic patients receiving secukinumab and ixekizumab, the anti-interleukin-17A monoclonal antibodies.

Authors:  Chen-Yu Wu; Hsien-Yi Chiu; Tsen-Fang Tsai
Journal:  PLoS One       Date:  2019-12-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.